Last reviewed · How we verify
NCT04336358
Telemedicine for First Trimester Abortion in South Africa
NA trial testing Telemedicine in Abortion in First Trimester in 900 participants. Status unknown.
30 September 2021
Quick facts
| Lead sponsor | University of Cape Town |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 900 |
| Start date | 27 February 2020 |
| Primary completion | 30 September 2021 |
| Estimated completion | 15 November 2021 |
| Sites | 4 locations across South Africa |
Drugs / interventions tested
- Telemedicine
Conditions studied
- Abortion in First Trimester — all drugs for Abortion in First Trimester →
Sponsor
University of Cape Town
Who can join
Adults 18 to 44, female only, with Abortion in First Trimester. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aim to determine if medical abortion facilitated by a physician online (s.c. telemedicine), combined with a simplified physical exam, is equally effective, safe and acceptable to women in South Africa as standard medical abortion care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
Endler M, Petro G, Gemzell Danielsson K, Grossman D, et al · · 2022 · cited 23× · PMID 36030811 · DOI 10.1016/s0140-6736(22)01474-x
Verify or expand the search:
- PubMed search for NCT04336358
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Telemedicine
Trials testing the same drug.
- NCT07059884 — Distance-Based Exercise to Preserve Function and Prevent Disability · NA · recruiting
- NCT07091617 — Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer · NA · recruiting
- NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting
- NCT07124546 — Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancer · NA · recruiting
- NCT06896539 — Telemedicine for Contraceptive Counselling- An Open Randomized Controlled Trial · NA · not yet recruiting
Other recruiting trials for Abortion in First Trimester
Currently open trials in the same condition.
- NCT06787274 — Research on Equity in Abortion Care by TeleHealth · recruiting
Other University of Cape Town trials
Trials by the same sponsor.
- NCT06997328 — '5 Rs to Rescue' A Cluster Trial With an Embedded Process Evaluation · recruiting
- NCT06431321 — Evaluation of a 2-session Parent Training Programme for Caregivers of Younger Children in Zimbabwe · NA · not yet recruiting
- NCT06051526 — The African Critical Illness Outcomes Study · completed
- NCT05723484 — Comparing a Novel Point-of-care Cytokine Biomarker Lateral Flow Test With Nucleic Acid Amplification Tests for Detection · completed
- NCT05681871 — South African Paediatric Surgical Outcomes Study 2 · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04336358 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Cape Town
- Last refreshed: 30 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04336358.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing